Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.
- NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_assertion description "[Doxazosin (dox), a selective alpha(1)-adrenergic receptor antagonist, used to treat hypertension, also inhibits prostate cancer cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.
- NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_assertion evidence source_evidence_literature NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.
- NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_assertion SIO_000772 16020484 NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.
- NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_assertion wasDerivedFrom befree-2016 NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.
- NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_assertion wasGeneratedBy ECO_0000203 NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.
- befree-2016 importedOn "2016-02-19" NP504239.RAUy-zTO9Z58tam44JBH4Uatoechjwh7YcQdowDwzhoGs130_provenance.